These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 18705027

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
    Apostol G, Pakalnis A, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, Saltarelli M.
    Headache; 2009 Jan; 49(1):36-44. PubMed ID: 19040678
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
    Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S, Mathew N, Winner PK, Deaton R, Sommerville K, Depakote ER Migraine Study Group.
    Neurology; 2002 Jun 11; 58(11):1652-9. PubMed ID: 12058094
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
    Klapper J.
    Cephalalgia; 1997 Apr 11; 17(2):103-8. PubMed ID: 9137847
    [Abstract] [Full Text] [Related]

  • 6. Migraine prophylaxis with divalproex.
    Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, Rapoport AM, Silber CJ, Deaton RL.
    Arch Neurol; 1995 Mar 11; 52(3):281-6. PubMed ID: 7872882
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
    Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M.
    J Am Acad Child Adolesc Psychiatry; 2009 May 11; 48(5):519-532. PubMed ID: 19325497
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb 11; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 11; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 14. Divalproex sodium in the treatment of migraine and cluster headaches.
    Gallagher RM, Mueller LL, Freitag FG.
    J Am Osteopath Assoc; 2002 Feb 11; 102(2):92-4. PubMed ID: 11866398
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Feb 11; 17(9):653-67. PubMed ID: 12828501
    [Abstract] [Full Text] [Related]

  • 18. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group.
    Headache; 2010 Jun 11; 50(6):921-36. PubMed ID: 20487038
    [Abstract] [Full Text] [Related]

  • 19. Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis.
    Green MW, Giordano S, Jiang P, Jafari M, Smith TB.
    Headache; 2005 Sep 11; 45(8):1031-7. PubMed ID: 16109117
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.